IgA Nephropathy is a leading cause of kidney failure. The 2025 KDIGO guidelines have transformed treatment-early combination therapy, new drugs like Nefecon, and tighter proteinuria targets offer real hope. But access and cost remain major barriers.
IgA Nephropathy is a leading cause of kidney failure. The 2025 KDIGO guidelines have transformed treatment-early combination therapy, new drugs like Nefecon, and tighter proteinuria targets offer real hope. But access and cost remain major barriers.
Health and Wellness
